Michelle A. Sargent

7.7k total citations · 2 hit papers
67 papers, 5.9k citations indexed

About

Michelle A. Sargent is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Michelle A. Sargent has authored 67 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 31 papers in Cardiology and Cardiovascular Medicine and 10 papers in Surgery. Recurrent topics in Michelle A. Sargent's work include Muscle Physiology and Disorders (19 papers), Cardiac Fibrosis and Remodeling (18 papers) and Signaling Pathways in Disease (17 papers). Michelle A. Sargent is often cited by papers focused on Muscle Physiology and Disorders (19 papers), Cardiac Fibrosis and Remodeling (18 papers) and Signaling Pathways in Disease (17 papers). Michelle A. Sargent collaborates with scholars based in United States, Germany and Australia. Michelle A. Sargent's co-authors include Jeffery D. Molkentin, Allen J. York, Jeffrey Robbins, Ronald J. Vagnozzi, Marjorie Maillet, Douglas P. Millay, Hadi Khalil, Jason Karch, Hanna Osińska and Jennifer A. Schwanekamp and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Michelle A. Sargent

67 papers receiving 5.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart

2018 451 citations Hadi Khalil, Onur Kanisicak et al. Journal of Clinical Investigation profile →
An acute immune response underlies the benefit of cardiac stem cell therapy

2019 411 citations Ronald J. Vagnozzi, Marjorie Maillet et al. profile →

Peers

Countries citing papers authored by Michelle A. Sargent

Since Specialization

Citations

This map shows the geographic impact of Michelle A. Sargent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle A. Sargent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle A. Sargent more than expected).

Fields of papers citing papers by Michelle A. Sargent

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle A. Sargent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle A. Sargent. The network helps show where Michelle A. Sargent may publish in the future.

Co-authorship network of co-authors of Michelle A. Sargent

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle A. Sargent. A scholar is included among the top collaborators of Michelle A. Sargent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle A. Sargent. Michelle A. Sargent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Col1a2-Deleted Mice Have Defective Type I Collagen and Secondary Reactive Cardiac Fibrosis with Altered Hypertrophic Dynamics 2023 ·Cells ·Stephanie Bowers, Qinghang Meng, Yasuhide Kuwabara, Jiuzhou Huo, (unknown), Allen J. York, Michelle A. Sargent, Vikram Prasad, Anthony J. Saviola, (unknown), Kirk C. Hansen, Ronald J. Vagnozzi, Katherine E. Yutzey, Jeffery D. Molkentin	14
2	Thbs1 induces lethal cardiac atrophy through PERK-ATF4 regulated autophagy 2021 ·Nature Communications ·Davy Vanhoutte, Tobias G. Schips, (unknown), Kelly M. Grimes, Tanya A. Baldwin, Matthew J. Brody, Federica Accornero, Michelle A. Sargent, Jeffery D. Molkentin	109
3	Inhibition of mitochondrial permeability transition by deletion of the ANT family and CypD 2019 ·Science Advances ·Jason Karch, Michael J. Bround, Hadi Khalil, Michelle A. Sargent, (unknown), Naohiro Terada, Pablo M. Peixoto, Jeffery D. Molkentin	176
4	Inhibiting Fibronectin Attenuates Fibrosis and Improves Cardiac Function in a Model of Heart Failure 2018 ·Circulation ·Íñigo Valiente-Alandí, Sarah J. Potter, Ane Salvador, Allison Schafer, Tobias G. Schips, Francisco J. Carrillo‐Salinas, Aaron M. Gibson, Michelle L. Nieman, Charles Perkins, Michelle A. Sargent, Jiuzhou Huo, John N. Lorenz, Tony DeFalco, Jeffery D. Molkentin, Pilar Alcaide, Burns C. Blaxall	198
5	Pharmacological and Activated Fibroblast Targeting of Gβγ-GRK2 After Myocardial Ischemia Attenuates Heart Failure Progression 2017 ·Journal of the American College of Cardiology ·Joshua G. Travers, Fadia Kamal, Íñigo Valiente-Alandí, Michelle L. Nieman, Michelle A. Sargent, John N. Lorenz, Jeffery D. Molkentin, Burns C. Blaxall	48
6	TGFBI functions similar to periostin but is uniquely dispensable during cardiac injury 2017 ·PLoS ONE ·Jennifer A. Schwanekamp, Angela Lorts, Michelle A. Sargent, Allen J. York, Kelly M. Grimes, (unknown), Jason J. Gokey, Jeffrey A. Whitsett, Simon J. Conway, Jeffery D. Molkentin	30
7	Genetic overexpression of Serpina3n attenuates muscular dystrophy in mice 2016 ·Human Molecular Genetics ·(unknown), Tobias G. Schips, Onur Kanisicak, Michelle A. Sargent, Jeffery D. Molkentin	28
8	Nemo-Like Kinase (NLK) Is a Pathological Signaling Effector in the Mouse Heart 2016 ·PLoS ONE ·Ruijie Liu, Hadi Khalil, Suh‐Chin J. Lin, Michelle A. Sargent, Allen J. York, Jeffery D. Molkentin	6
9	Cathepsin S Contributes to the Pathogenesis of Muscular Dystrophy in Mice 2016 ·Journal of Biological Chemistry ·(unknown), Tobias G. Schips, Michelle A. Sargent, Davy Vanhoutte, Onur Kanisicak, Vikram Prasad, Suh‐Chin J. Lin, Marjorie Maillet, Jeffery D. Molkentin	18
10	Necroptosis Interfaces with MOMP and the MPTP in Mediating Cell Death 2015 ·PLoS ONE ·Jason Karch, Onur Kanisicak, Matthew J. Brody, Michelle A. Sargent, (unknown), Jeffery D. Molkentin	86
11	Genetic deletion of the mitochondrial phosphate carrier desensitizes the mitochondrial permeability transition pore and causes cardiomyopathy 2014 ·Cell Death and Differentiation ·Jennifer Q. Kwong, Jennifer Davis, Christopher Baines, Michelle A. Sargent, Jason Karch, Xuejun Wang, Taosheng Huang, Jeffery D. Molkentin	131
12	Enhanced Ca2+ influx from STIM1–Orai1 induces muscle pathology in mouse models of muscular dystrophy 2014 ·Human Molecular Genetics ·Sanjeewa A. Goonasekera, Jennifer Davis, Jennifer Q. Kwong, Federica Accornero, Lan Wei‐LaPierre, Michelle A. Sargent, Robert T. Dirksen, Jeffery D. Molkentin	60
13	Lipophilic Prodrugs of FR900098 Are Antimicrobial against Francisella novicida In Vivo and In Vitro and Show GlpT Independent Efficacy 2012 ·PLoS ONE ·(unknown), Michelle A. Sargent, (unknown), (unknown), (unknown), (unknown), Robin D. Couch, Cynthia S. Dowd, Monique L. van Hoek	40
14	Decreased cardiac L-type Ca2+ channel activity induces hypertrophy and heart failure in mice 2011 ·Journal of Clinical Investigation ·Sanjeewa A. Goonasekera, Karin Hammer, Mannix Auger‐Messier, Ilona Bódi, Xiongwen Chen, Hongyu Zhang, Steven Reiken, John W. Elrod, Robert N. Correll, Allen J. York, Michelle A. Sargent, Franz Hofmann, Sven Moosmang, Andrew R. Marks, Steven R. Houser, Donald M. Bers, Jeffery D. Molkentin	132
15	Genetic Manipulation of Dysferlin Expression in Skeletal Muscle 2009 ·American Journal Of Pathology ·Douglas P. Millay, Marjorie Maillet, Joseph A. Roche, Michelle A. Sargent, Elizabeth M. McNally, Robert J. Bloch, Jeffery D. Molkentin	51
16	Calcineurin protects the heart in a murine model of dilated cardiomyopathy 2009 ·Journal of Molecular and Cellular Cardiology ·Joerg Heineke, Kai C. Wollert, Hanna Osińska, Michelle A. Sargent, Allen J. York, Jeffrey Robbins, Jeffery D. Molkentin	35
17	DUSP6 (MKP3) Null Mice Show Enhanced ERK1/2 Phosphorylation at Baseline and Increased Myocyte Proliferation in the Heart Affecting Disease Susceptibility 2008 ·Journal of Biological Chemistry ·Marjorie Maillet, Nicole H. Purcell, Michelle A. Sargent, Allen J. York, Orlando F. Bueno, Jeffery D. Molkentin	145
18	Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy 2008 ·Nature Medicine ·Douglas P. Millay, Michelle A. Sargent, Hanna Osińska, Christopher Baines, Elisabeth R. Barton, Grégoire Vuagniaux, H. Lee Sweeney, Jeffrey Robbins, Jeffery D. Molkentin	290
19	Inducible and myocyte-specific inhibition of PKCα enhances cardiac contractility and protects against infarction-induced heart failure 2007 ·American Journal of Physiology-Heart and Circulatory Physiology ·(unknown), Allen J. York, Michelle A. Sargent, Robert A. Kaiser, John N. Lorenz, Jeffrey Robbins, Jeffery D. Molkentin	37
20	Age-Dependent Effect of Myostatin Blockade on Disease Severity in a Murine Model of Limb-Girdle Muscular Dystrophy 2006 ·American Journal Of Pathology ·Stephanie A. Parsons, Douglas P. Millay, Michelle A. Sargent, Elizabeth M. McNally, Jeffery D. Molkentin	80

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact